EXETER, N.H.--(BUSINESS WIRE)--
Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm”), a global medical technology
company focused on the development and commercialization of its
proprietary Hi-VNI® Technology products that are used to
treat patients of all ages suffering from respiratory distress, today
announced the closing of its initial public offering of 4,600,000 shares
of common stock, at a price to the public of $14.00 per share, which
includes the exercise in full by the underwriters of their option to
purchase up to an additional 600,000 shares of common stock. The gross
proceeds from the offering are $64.4 million, before deducting
underwriting discounts and commissions and offering expenses. All of the
shares of common stock were offered by Vapotherm. The shares began
trading on the New York Stock Exchange under the ticker symbol “VAPO” on
November 14, 2018.
BofA Merrill Lynch and William Blair acted as joint book-running
managers. Canaccord Genuity LLC acted as lead manager, and BTIG, LLC
acted as co-manager.
A registration statement relating to the securities has been filed with,
and declared effective by, the Securities and Exchange Commission. This
press release shall not constitute an offer to sell or the solicitation
of an offer to buy, nor shall there be any sale of these securities in
any state or jurisdiction in which such offer, solicitation, or sale
would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
The offering was made only by means of a prospectus. A copy of the final
prospectus may be obtained from BofA Merrill Lynch, Attention: BofA
Merrill Lynch, NC1-004-03-43, 200 North College Street, 3rd floor,
Charlotte, NC 28255-0001, Attn: Prospectus Department, or email at dg.prospectus_requests@baml.com,
or from William Blair & Company, L.L.C., Attention: Prospectus
Department, 150 North Riverside Plaza, Chicago, IL 60606; via telephone
at (800) 621-0687 or via email at prospectus@williamblair.com.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20181116005393/en/
Investor Contacts: Mark Klausner or Mike Vallie, Westwicke Partners, ir@vtherm.com,
+1-855-255-7410
Source: Vapotherm, Inc.